Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

Neuropsychopharmacology. 2018 Apr;43(5):1021-1031. doi: 10.1038/npp.2017.175. Epub 2017 Aug 17.

Abstract

Cannabis affects cognitive performance through the activation of the endocannabinoid system, and the molecular mechanisms involved in this process are poorly understood. Using the novel object-recognition memory test in mice, we found that the main psychoactive component of cannabis, delta9-tetrahydrocannabinol (THC), alters short-term object-recognition memory specifically involving protein kinase C (PKC)-dependent signaling. Indeed, the systemic or intra-hippocampal pre-treatment with the PKC inhibitors prevented the short-term, but not the long-term, memory impairment induced by THC. In contrast, systemic pre-treatment with mammalian target of rapamycin complex 1 inhibitors, known to block the amnesic-like effects of THC on long-term memory, did not modify such a short-term cognitive deficit. Immunoblot analysis revealed a transient increase in PKC signaling activity in the hippocampus after THC treatment. Thus, THC administration induced the phosphorylation of a specific Ser residue in the hydrophobic-motif at the C-terminal tail of several PKC isoforms. This significant immunoreactive band that paralleled cognitive performance did not match in size with the major PKC isoforms expressed in the hippocampus except for PKCθ. Moreover, THC transiently enhanced the phosphorylation of the postsynaptic calmodulin-binding protein neurogranin in a PKC dependent manner. These data demonstrate that THC alters short-term object-recognition memory through hippocampal PKC/neurogranin signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anisomycin / pharmacology
  • Dizocilpine Maleate / pharmacology
  • Dose-Response Relationship, Drug
  • Dronabinol / antagonists & inhibitors
  • Dronabinol / pharmacology*
  • Drug Interactions
  • Hippocampus / drug effects*
  • Hippocampus / enzymology*
  • Isoenzymes / metabolism
  • Male
  • Memory, Short-Term / drug effects*
  • Mice
  • Microinjections
  • Neurogranin / metabolism
  • Phenols / pharmacology
  • Phosphorylation / drug effects
  • Piperidines / pharmacology
  • Protein Kinase C / metabolism*
  • Quinoxalines / pharmacology
  • Rimonabant / pharmacology
  • Signal Transduction / drug effects*
  • Sirolimus / analogs & derivatives
  • Sirolimus / pharmacology

Substances

  • 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione
  • Isoenzymes
  • Phenols
  • Piperidines
  • Quinoxalines
  • Ro 25-6981
  • Neurogranin
  • NPC 15437
  • temsirolimus
  • Anisomycin
  • Dizocilpine Maleate
  • Dronabinol
  • Protein Kinase C
  • Rimonabant
  • Sirolimus